In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cardinal Health to acquire Alaris Medical for $2bn

Executive Summary

Cardinal Health has signed a definitive agreement to acquire Alaris Medical Systems (intravenous medication safety products) for $2bn, or roughly 4 times Alaris's 2003 sales. In a tender offer, Cardinal will pay $22.35 cash for each outstanding Alaris share (a 12% premium to the market average) and will also assume about $400mm in debt.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Consumables, Central Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies